“I literally placed my life in RMCC's guiding hands, and they gently maneuvered me through the maze of "stem cell transplant."”

Doris
Transplant Survivor

Clinical Information

It is because of you, our referring physician partners, that Rocky Mountain Cancer Centers has become Colorado's largest and most comprehensive provider of cancer care. RMCC provides a full spectrum of cancer care services, including medical oncology, radiation oncology, gynecologic oncology, hematology, genetic counseling and bone marrow transplants.

As a resource to our valued physician partners, the following section provides clinical and technical information on RMCC's research programs and latest technologies.

Partial-Breast Intensity-Modulated Radiotherapy study
RMCC, Dr. Charles Leonard, Dr. Kathryn Howell and Dr. Dennis Carter are taking part in a clinical investigation, prospective trial of accelerated partial-breast intensity-modulated radiotherapy (IMRT). This study was published in the International Journal of Radiation Oncology.
Pegylated liposomal doxorubicin as single-agent treatment of low-grade non-Hodgkin's lymphoma: a phase II multicenter study.

DiBella NJ, Khan MM, Dakhil SR, Logie KW, Marsland TA, Weinstein RE, Mirabel MY, Asmar L.
PET Case Study #1
PET detects significantly more disease than the CT scan, Gallium scan and Bone scan combined.
PET Case Study #2
Medicare and Medicaid Approve PET for Breast Cancer.
PET Case Study #3
RMCC's PET Institute's PET/CT Mobile Scanner: Improved Accuracy and Specificity.